Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Schmitt

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Klinische Monatsblatter Fur Augenheilkunde|March 1, 2003
[Prism correction in vision disparity based on the "H. J. Haase measurement and correction methodology"]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Vision Research|May 14, 2003
Ocular prevalence versus ocular dominanceGuntram Kommerell, Christina Schmitt, Miriam Kromeier, et al.
Klinische Monatsblatter Fur Augenheilkunde|July 24, 2002
[Do prisms according to Hans-Joachim Haase improve stereoacuity?]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Interindividual variability of learning in stereoacuityChristina Schmitt, Miriam Kromeier, Michael Bach, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|January 22, 2003
Stereoacuity versus fixation disparity as indicators for vergence accuracy under prismatic stressMiriam Kromeier, Christina Schmitt, Michael Bach, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 28, 2003
[Do prisms according to Hans-Joachim Haase influence ocular prevalence?]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Dermatologie (Heidelberg, Germany)|September 21, 2022
[Papules, plaques and pruritus]Christina Schmitt, Felix Lauffer, Tilo Biedermann, et al.
Oncology Reports|September 19, 2018
APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistanceChristina Schmitt, Ralph Lucius, Michael Synowitz, et al.
International Journal of Cancer|June 10, 2003
Exclusion of BRAFV599E as a melanoma susceptibility mutationPeter Meyer, Ruediger Klaes, Christina Schmitt, et al.
Journal of Cancer Research and Clinical Oncology|December 18, 2019
Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cellsMoiken Mehner, Carolin Kubelt, Vivian Adamski, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Klinische Monatsblatter Fur Augenheilkunde|March 1, 2003
[Prism correction in vision disparity based on the "H. J. Haase measurement and correction methodology"]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Vision Research|May 14, 2003
Ocular prevalence versus ocular dominanceGuntram Kommerell, Christina Schmitt, Miriam Kromeier, et al.
Klinische Monatsblatter Fur Augenheilkunde|July 24, 2002
[Do prisms according to Hans-Joachim Haase improve stereoacuity?]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 25, 2002
Interindividual variability of learning in stereoacuityChristina Schmitt, Miriam Kromeier, Michael Bach, et al.
Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|January 22, 2003
Stereoacuity versus fixation disparity as indicators for vergence accuracy under prismatic stressMiriam Kromeier, Christina Schmitt, Michael Bach, et al.
Klinische Monatsblatter Fur Augenheilkunde|January 28, 2003
[Do prisms according to Hans-Joachim Haase influence ocular prevalence?]Miriam Kromeier, Christina Schmitt, Michael Bach, et al.
Dermatologie (Heidelberg, Germany)|September 21, 2022
[Papules, plaques and pruritus]Christina Schmitt, Felix Lauffer, Tilo Biedermann, et al.
Oncology Reports|September 19, 2018
APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistanceChristina Schmitt, Ralph Lucius, Michael Synowitz, et al.
International Journal of Cancer|June 10, 2003
Exclusion of BRAFV599E as a melanoma susceptibility mutationPeter Meyer, Ruediger Klaes, Christina Schmitt, et al.
Journal of Cancer Research and Clinical Oncology|December 18, 2019
Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cellsMoiken Mehner, Carolin Kubelt, Vivian Adamski, et al.
Pageof 4